Join the India Equity Telegram Group for analysis, updates and results
NURECA has declared results for the period ended Sep 2021.
Quarterly Results
[s2If !current_user_can(access_s2member_level1)] Register and Login below to read result analysis [lwa][/s2If] [s2If current_user_can(access_s2member_level1)]
- Sales for period ended Sep 2021 is Rs 46.91 cr compared to Rs 91.92 cr for period ended Sep 2020, a fall of 49.0%
- Operating Profits reported at Rs 6.06 cr for period ended Sep 2021 vis-vis 36.24 for period ended Sep 2020 .
- Operating Margins contracted -2650.7 bps for period ended Sep 2021 vis-vis Sep 2020 .
- The EPS for Sep 2021 was Rs 5.49 compared to Rs 36.15 for previous quarter ended Jun 2021 and Rs 0 for Sep 2020
- The stock is trading at Rs 1823.30 and a market cap of Rs 1823 cr
[/s2If]
Trading Chart
Further analysis and Full Company Research with investing scores is available here: NURECA
Join BharatEquity Telegram Channel for updated India results, analysis and News
Join Our Twitter